VAQTA 25U SYR 10X0.5ML
$413.43 RESTRICTED - NOT ON FORMULARY
Availability: 1 in stock (can be backordered)
VAQTA® [Hepatitis A Vaccine, Inactivated] is indicated for the prevention of disease caused by hepatitis A virus (HAV) in persons 12 months of age and older
VAQTA is a sterile suspension for intramuscular injection
One milliliter of the vaccine contains approximately 50U of hepatitis A virus antigen, which is purified and formulated without a preservative
Each 0.5-mL pediatric dose contains 25U of hepatitis A virus antigen and adsorbed onto approximately 0.225 mg of aluminum provided as amorphous aluminum hydroxy phosphate sulfate, and 35 mcg of sodium borate as a pH stabilizer, in 0.9% sodium chloride
| Units of Measurement | |
|---|---|
| Manufacturer | MERCK |
| UNSPSC | 51201626 |
| Product Specification Sheet |
